Carisma Therapeutics Inc (CARM)

02:34 AM

Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace

02:34 AM

Apr 03, 2025

Carisma Therapeutics Focuses on Strategic Alternatives Amid Revised Operating Plan - MyChesCo

Apr 03, 2025

Apr 02, 2025

Philly’s Carisma Therapeutics slashed its workforce to 6 from 46 for sale or wind down - MSN

Apr 02, 2025

Apr 02, 2025

Carisma Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Apr 02, 2025

Apr 02, 2025

Carisma Therapeutics (NASDAQ:CARM) Price Target Lowered to $1.00 at D. Boral Capital - Defense World

Apr 02, 2025

Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025

Apr 01, 2025

Carisma Therapeutics to Present at AASLD 2024 on Liver Fibrosis Treatment - MSN

Apr 01, 2025

Mar 31, 2025

Penn spinout Carisma Therapeutics lays off 84% of its staff, explores possible sale - The Business Journals

Mar 31, 2025

Mar 31, 2025

Carisma Therapeutics Provides Corporate Updates - Citizen Tribune

Mar 31, 2025

Mar 31, 2025

Carisma Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025

Mar 31, 2025

Carisma Therapeutics Board Approves Revised Operating Plan; Reduces Workforce - MarketScreener

Mar 31, 2025

Mar 31, 2025

Carisma Therapeutics Inc. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

Carisma Therapeutics Explores Sale Options as Company Halts R&D Programs - Stock Titan

Mar 31, 2025

Mar 28, 2025

Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Business And Shares Still Trailing The Industry - simplywall.st

Mar 28, 2025

Mar 28, 2025

Carisma Therapeutics (CARM) to Release Earnings on Monday - Defense World

Mar 28, 2025

Mar 22, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Consensus Rating of “Hold” from Analysts - Defense World

Mar 22, 2025

Mar 13, 2025

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annua - GuruFocus.com

Mar 13, 2025

Feb 25, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Feb 25, 2025

Feb 22, 2025

Michael Klichinsky to Speak at H.C. Wainwright Cell Therapy Virtual Conference - MSN

Feb 22, 2025

Feb 19, 2025

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024 - Quantisnow

Feb 19, 2025

Feb 19, 2025

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference - Quantisnow

Feb 19, 2025

Feb 11, 2025

Carisma Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Conference - MSN

Feb 11, 2025

Feb 05, 2025

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Quantisnow

Feb 05, 2025

Feb 04, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Short Interest Update - Defense World

Feb 04, 2025

Jan 31, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

Jan 31, 2025

Jan 30, 2025

Why Meta Platforms Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Jan 30, 2025

Jan 22, 2025

BTIG Downgrades Carisma Therapeutics (CARM) - MSN

Jan 22, 2025

Jan 18, 2025

Evercore ISI Group Downgrades Carisma Therapeutics (CARM) - MSN

Jan 18, 2025

Jan 18, 2025

Barclays PLC Has $539,000 Holdings in Carisma Therapeutics, Inc. (NASDAQ:CARM) - Defense World

Jan 18, 2025

Jan 14, 2025

Carisma Therapeutics (NASDAQ:CARM) Given “Buy” Rating at D. Boral Capital - Defense World

Jan 14, 2025

Jan 14, 2025

Geode Capital Management LLC Lowers Holdings in Carisma Therapeutics, Inc. (NASDAQ:CARM) - Defense World

Jan 14, 2025

Jan 11, 2025

Carisma Therapeutics faces Nasdaq delisting over share price - Investing.com India

Jan 11, 2025

Jan 10, 2025

Carisma Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com Canada

Jan 10, 2025

Jan 06, 2025

Carisma Therapeutics, Inc. (NASDAQ:CARM) Receives Average Rating of “Hold” from Analysts - Defense World

Jan 06, 2025

Jan 03, 2025

Barclays PLC Grows Holdings in Carisma Therapeutics, Inc. (NASDAQ:CARM) - Defense World

Jan 03, 2025

Dec 30, 2024

Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023 - GuruFocus.com

Dec 30, 2024

Dec 27, 2024

4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology - Quantisnow

Dec 27, 2024

Dec 26, 2024

Carisma Therapeutics Appoints Interim VP of Finance - TipRanks

Dec 26, 2024

Dec 20, 2024

Carisma Therapeutics Refocuses Strategy, Reduces Workforce Amid Pipeline Reprioritization - MSN

Dec 20, 2024

Dec 18, 2024

Carisma downgraded by H.C. Wainwright to neutral - MSN

Dec 18, 2024

Dec 17, 2024

Carisma Therapeutics (NASDAQ:CARM) Given Neutral Rating at HC Wainwright - Defense World

Dec 17, 2024

Dec 16, 2024

HC Wainwright & Co. Downgrades Carisma Therapeutics (CARM) - MSN

Dec 16, 2024

Dec 16, 2024

Carisma shares downgraded to neutral after program halt - Investing.com

Dec 16, 2024